Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study

被引：0

|

作者：

Haider, Karim S.

Haider, Ahmad

Saad, Farid

机构：

来源：

DIABETES | 2019年 / 68卷

关键词：

D O I：

10.2337/db19-1123-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1123-P

引用

收藏

页数：2

相关论文

共 50 条

[1] Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2019, 68
[2] Improvement of Type 2 Diabetes (T2DM) and Reduction of Major Adverse Cardiovascular Events and Mortality in Hypogonadal Men Receiving Long-Term Treatment with Injectable Testosterone Undecanoate ( TU)-Real-Life Evidence from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2018, 67
[3] Beneficial Changes in Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Registry
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2019, 68
[4] Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Type 2 Diabetes (T2DM) and Mortality in Hypogonadal Men
Saad, Farid
Haider, Ahmad
Doros, Gheorghe
Traish, Abdulmaged
DIABETES, 2016, 65 : A271 - A271
[5] Mortality, Major Adverse Cardiovascular Events (MACE) and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes on Long-Term Testosterone Treatment: An Update from a Urological Registry Study
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2022, 71
[6] Mortality, Major Adverse Cardiovascular Events (MACDE), and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): 11-Year Real-World Data
Haider, Ahmad
Haider, Karim S.
Saad, Farid
DIABETES, 2020, 69
[7] Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2019, 68
[8] Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data
Haider, Karim S.
Haider, Ahmad
Saad, Farid
DIABETES, 2021, 70
[9] Sustained Improvement of Obesity in Hypogonadal Men with Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU)-Real-Life Evidence from a Urological Registry Study
Saad, Farid
Haider, Karim S.
Haider, Ahmad
DIABETES, 2018, 67
[10] REMISSION OF TYPE 2 DIABETES, MORTALITY, AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN MEN WITH HYPOGONADISM AND TYPE 2 DIABETES RECEIVING LONG-TERM TESTOSTERONE THERAPY IN COMPARISON TO AN UNTREATED CONTROL GROUP IN A UROLOGICAL REGISTRY STUDY
Haider, K. S.
Haider, A.
Doros, G.
Traish, A.
Saad, F.
JOURNAL OF SEXUAL MEDICINE, 2023, 20

← 1 2 3 4 5 →